SANDOSTATINE 100 micrograms/1 ml, solution for injection/for infusion 6 ampoules of 1 ml
Active ingredients: Octreotide acetate, Octreotide
Commercialized according to BDPMDispensing in France: Prescription only
Solution for injection or infusion6 ampoules of 1 mlintraveineuse;sous-cutanée
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- SANDOSTATINE 100 microgrammes/1 mL, solution injectable/pour perfusion
- Pharmaceutical form
- solution injectable ou pour perfusion
- Route of administration
- intraveineuse;sous-cutanée
- Presentation description
- 6 ampoule(s) en verre de 1 ml
- Marketing authorisation holder
- NOVARTIS PHARMA
- Reimbursement according to BDPM
- 100%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 1 Oct 1998
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Initial prescription by a hospital doctor
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
66004031CIP73424427CIP133400934244278Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| ACÉTATE D'OCTRÉOTIDEsolution | — | SA |
| OCTRÉOTIDEsolution | 0,100 mg · une ampoule | FT |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.